中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
10期
204-205
,共2页
肠易激综合征%双歧杆菌四联活菌片%曲美布汀%谷维素
腸易激綜閤徵%雙歧桿菌四聯活菌片%麯美佈汀%穀維素
장역격종합정%쌍기간균사련활균편%곡미포정%곡유소
Irritable bowel syndrome%Bifidobacterium tetravaccine tablet%Trimebutine%Oryzanol
目的：探讨双歧杆菌四联活菌片（思连康）、曲美布汀联合谷维素治疗肠易激综合征的临床疗效。方法选取我院收治的肠易激综合征患者共43例，并对其随机分为治疗组和对照组。治疗组患者共有22例，对照组患者21例，对照组采取常规治疗方式。治疗组采用思连康、曲美布汀联合谷维素的方式治疗。结果治疗组总有效率为100.00%；对照组总有效率为80.95%，差异具有统计学意义，P<0.05。结论思连康、曲美布汀联合谷维素在治疗肠易激综合征中有显著疗效，且不良反应较少。
目的：探討雙歧桿菌四聯活菌片（思連康）、麯美佈汀聯閤穀維素治療腸易激綜閤徵的臨床療效。方法選取我院收治的腸易激綜閤徵患者共43例，併對其隨機分為治療組和對照組。治療組患者共有22例，對照組患者21例，對照組採取常規治療方式。治療組採用思連康、麯美佈汀聯閤穀維素的方式治療。結果治療組總有效率為100.00%；對照組總有效率為80.95%，差異具有統計學意義，P<0.05。結論思連康、麯美佈汀聯閤穀維素在治療腸易激綜閤徵中有顯著療效，且不良反應較少。
목적：탐토쌍기간균사련활균편（사련강）、곡미포정연합곡유소치료장역격종합정적림상료효。방법선취아원수치적장역격종합정환자공43례，병대기수궤분위치료조화대조조。치료조환자공유22례，대조조환자21례，대조조채취상규치료방식。치료조채용사련강、곡미포정연합곡유소적방식치료。결과치료조총유효솔위100.00%；대조조총유효솔위80.95%，차이구유통계학의의，P<0.05。결론사련강、곡미포정연합곡유소재치료장역격종합정중유현저료효，차불량반응교소。
Objective To explore the clinical efficacy of Bifidobacterium tetravaccine tablet (siliankang) and trimebutine combined with oryzanol on irritable bowel syndrome. Methods 43 patients with irritable bowel syndrome in our hospital were randomly selected into treatment group(22 cases)and control group(21 cases). The patients in control group received conventional treatment,the treatment group patients were treated with siliankang and trimebutine combined with oryzanol. Results The total effective rate in the treatment group was 100%,the control group was 80.95%,the difference was significant,P<0.05. Conclusion The clinical efficacy of siliankang and trimebutine combined with oryzanol on irritable bowel syndrome is remarkable,with less adverse reactions.
